Cargando…
Silencing of immune activation with methotrexate in patients with COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247505/ https://www.ncbi.nlm.nih.gov/pubmed/32471659 http://dx.doi.org/10.1016/j.jns.2020.116942 |
| _version_ | 1783538169765953536 |
|---|---|
| author | Safavi, Farinaz Nath, Avindra |
| author_facet | Safavi, Farinaz Nath, Avindra |
| author_sort | Safavi, Farinaz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7247505 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72475052020-05-26 Silencing of immune activation with methotrexate in patients with COVID-19 Safavi, Farinaz Nath, Avindra J Neurol Sci Article Elsevier 2020-08-15 2020-05-25 /pmc/articles/PMC7247505/ /pubmed/32471659 http://dx.doi.org/10.1016/j.jns.2020.116942 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Safavi, Farinaz Nath, Avindra Silencing of immune activation with methotrexate in patients with COVID-19 |
| title | Silencing of immune activation with methotrexate in patients with COVID-19 |
| title_full | Silencing of immune activation with methotrexate in patients with COVID-19 |
| title_fullStr | Silencing of immune activation with methotrexate in patients with COVID-19 |
| title_full_unstemmed | Silencing of immune activation with methotrexate in patients with COVID-19 |
| title_short | Silencing of immune activation with methotrexate in patients with COVID-19 |
| title_sort | silencing of immune activation with methotrexate in patients with covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247505/ https://www.ncbi.nlm.nih.gov/pubmed/32471659 http://dx.doi.org/10.1016/j.jns.2020.116942 |
| work_keys_str_mv | AT safavifarinaz silencingofimmuneactivationwithmethotrexateinpatientswithcovid19 AT nathavindra silencingofimmuneactivationwithmethotrexateinpatientswithcovid19 |